Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

ABCLABCL
Showing 8 of 11 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ABCELLERA BIOLOGICS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 4.3M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $33.9M as of 2026-Q2. The position was decreased (-43.0% shares). ABCL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$33.9M

Current Shares

4.3M

Total Value Change

+$22M

Total Shares Change

-272,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.3M
-43.0%
$33.9M0.0%$7.85
0
2026-Q1
Decreased
7.6M
-3.8%
$26.4M0.0%$3.71
0
2025-Q4
New
7.9M
-
$26.9M0.0%$3.45
40
2025-Q3
Exited
0
-100.0%
$00.0%$4.87
0
2025-Q2
Decreased
8.5M
-45.9%
$29.1M0.0%$3.61
0
2025-Q1
Increased
15.7M
+248.3%
$34.9M0.0%$2.31
47
2024-Q4
Decreased
4.5M
-2.0%
$13.2M0.0%$2.82
0
2024-Q3
Decreased
4.6M
-0.2%
$11.9M0.0%$2.61
0

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used